Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoline Ehlert

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Cancers|December 11, 2022
Immune Response and Outcome of High-Risk Neuroblastoma Patients Immunized with Anti-Idiotypic Antibody Ganglidiomab: Results from Compassionate-Use TreatmentsLeah Klingel, Nikolai Siebert, Sascha Troschke-Meurer, et al.
Oncoimmunology|December 22, 2016
Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and improved event-free survivalNikolai Siebert, Christian Jensen, Sascha Troschke-Meurer, et al.
Oncoimmunology|November 20, 2019
Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2Sascha Troschke-Meurer, Nikolai Siebert, Madlen Marx, et al.
American Journal of Ophthalmology Case Reports|July 28, 2020
Bone metastasis of retinoblastoma five years after primary treatmentSaskia C Ting, Tobias Kiefer, Karoline Ehlert, et al.
Journal of Inherited Metabolic Disease|March 1, 2019
Allogeneic hematopoietic cell transplantation in Farber diseaseKaroline Ehlert, Thierry Levade, Maja Di Rocco, et al.
Journal of Cancer Research and Clinical Oncology|October 8, 2021
Comparison of three different methods to detect bone marrow involvement in patients with neuroblastomaFelix Schriegel, Sabine Taschner-Mandl, Marie Bernkopf, et al.
Journal of Neurosurgery. Pediatrics|October 12, 2019
Neuroblastoma with intracerebral metastases and the need for neurosurgery: a single-center experienceSteffen Fleck, Sascha Marx, Clara Bobak, et al.
Frontiers in Pediatrics|December 19, 2022
Splenic rupture and fungal endocarditis in a pediatric patient with invasive fusariosis after allogeneic hematopoietic stem cell transplantation for aplastic anemia: A case reportMaurice Hannemann, Dunja Wilmes, Frank Dombrowski, et al.
Journal of Pediatric Hematology/Oncology|January 28, 2020
Treatment of Children With Cancer and/or Hematopoietic Stem Cell Transplantation in the Intensive Care Unit: Experience at a Large European Pediatric Cancer CenterCatharina T M M Barking, Katja Masjosthusmann, Georg Rellensmann, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 20, 2024
Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare diseaseDanai Papangelopoulou, Brigitte Bison, Lars Behrens, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Cancers|December 11, 2022
Immune Response and Outcome of High-Risk Neuroblastoma Patients Immunized with Anti-Idiotypic Antibody Ganglidiomab: Results from Compassionate-Use TreatmentsLeah Klingel, Nikolai Siebert, Sascha Troschke-Meurer, et al.
Oncoimmunology|December 22, 2016
Neuroblastoma patients with high-affinity FCGR2A, -3A and stimulatory KIR 2DS2 treated by long-term infusion of anti-GD<sub>2</sub> antibody ch14.18/CHO show higher ADCC levels and improved event-free survivalNikolai Siebert, Christian Jensen, Sascha Troschke-Meurer, et al.
Oncoimmunology|November 20, 2019
Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2Sascha Troschke-Meurer, Nikolai Siebert, Madlen Marx, et al.
American Journal of Ophthalmology Case Reports|July 28, 2020
Bone metastasis of retinoblastoma five years after primary treatmentSaskia C Ting, Tobias Kiefer, Karoline Ehlert, et al.
Journal of Inherited Metabolic Disease|March 1, 2019
Allogeneic hematopoietic cell transplantation in Farber diseaseKaroline Ehlert, Thierry Levade, Maja Di Rocco, et al.
Journal of Cancer Research and Clinical Oncology|October 8, 2021
Comparison of three different methods to detect bone marrow involvement in patients with neuroblastomaFelix Schriegel, Sabine Taschner-Mandl, Marie Bernkopf, et al.
Journal of Neurosurgery. Pediatrics|October 12, 2019
Neuroblastoma with intracerebral metastases and the need for neurosurgery: a single-center experienceSteffen Fleck, Sascha Marx, Clara Bobak, et al.
Frontiers in Pediatrics|December 19, 2022
Splenic rupture and fungal endocarditis in a pediatric patient with invasive fusariosis after allogeneic hematopoietic stem cell transplantation for aplastic anemia: A case reportMaurice Hannemann, Dunja Wilmes, Frank Dombrowski, et al.
Journal of Pediatric Hematology/Oncology|January 28, 2020
Treatment of Children With Cancer and/or Hematopoietic Stem Cell Transplantation in the Intensive Care Unit: Experience at a Large European Pediatric Cancer CenterCatharina T M M Barking, Katja Masjosthusmann, Georg Rellensmann, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|February 20, 2024
Brain stem tumors in children less than 3 months: Clinical and radiologic findings of a rare diseaseDanai Papangelopoulou, Brigitte Bison, Lars Behrens, et al.
Pageof 5